en
Scientific article
Open access
English

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses

First online date2021-10-26
Citation (ISO format)
SCHMIEDEBERG, Kristin et al. Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. In: The Lancet. Rheumatology, 2021. doi: 10.1016/S2665-9913(21)00328-3
Main files (1)
Article (Published version)
accessLevelPublic
Secondary files (1)
Identifiers
ISSN of the journal2665-9913
123views
49downloads

Technical informations

Creation11/17/2021 2:36:00 PM
First validation11/17/2021 2:36:00 PM
Update time03/16/2023 2:15:24 AM
Status update03/16/2023 2:15:22 AM
Last indexation01/29/2024 11:13:29 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack